Replies to post #727753 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

Yes I know, right again, as always Flip.

Still batting a thousand you are. Keep up the good work buddy.

I am still interested to hear your reasoning on how you think LP did not confirm at the ASM that they hadn't submitted to NICE yet.

I don't doubt you, you've never been wrong before, but I am curious how you hear this statement and come to the conclusion that the status of the NICE submission as of the ASM is anything but "not yet submitted":

After the MAA, and the commercialization preparation, and those activities, we also need to go through the process of applying for approval for reimbursement. So in the UK, that's a process that is handled by NICE. And NICE has been absolutely wonderful to us. I cannot say enough things wonderful about NICE. They've been supportive. They've been flexible. They're standing by.

We talk to them. They reach out to us every couple of months to check on the status of things. I mean, I couldn't imagine a government agency, that's been so supportive as they've been. What we will need to do is, we'll need to engage specialized consultants to develop, what's referred to, as a health economics model. We have to make an economic model about the cost benefits of the DC vaccine treatment, and how it fits with their policies, and that sort of thing. So, that for sure will be, in our grouping of top priority activities, over the, as we look forward, over the coming 18 month period, 12 months, whatever.

Thanks in advance for the education.